Drug profile · INN
alendronic acid
VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)
alendronic acid (VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)) is a farnesyl diphosphate synthase inhibitor.
EMA: approved Musculo-skeletal system (M05) M05BB03
Patents linked 1
Pipeline programs 2
News articles 0
Drug details — alendronic acid
- Class
- Musculo-skeletal system (M05)
- Route
- —
- Patents
- 1
- Programs
- 2
- Data quality
- 0.83
Quick answer
alendronic acid (VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)) is a farnesyl diphosphate synthase inhibitor.
Key facts
INN alendronic acid
Brand VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)
Mechanism Farnesyl diphosphate synthase inhibitor
Therapeutic class Musculo-skeletal system (M05)
ATC code M05BB03
Mechanism of action
Farnesyl diphosphate synthase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is alendronic acid?
alendronic acid (VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)) is a farnesyl diphosphate synthase inhibitor.
What is the brand name for alendronic acid?
VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD) is a marketed brand name for alendronic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.